• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PULMONX CORPORATION ZEPHYR ENDOBRONCHIAL VALVE (EBV)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PULMONX CORPORATION ZEPHYR ENDOBRONCHIAL VALVE (EBV) Back to Search Results
Model Number ZEPHYR 4.0 EBV
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pleural Effusion (2010)
Event Date 03/01/2021
Event Type  Injury  
Manufacturer Narrative
Pleural effusion is a known, anticipated side effect associated with the zephyr valve treatment (criner et al.A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (liberate).Am j respir crit care med.2018; 198 (9): 1151-1164).In the liberate study (ide clinical study used to support pma p180002's approval), 7.0% of the zephyr valve subjects and 0% of the control subjects experienced pleural effusion during the treatment period (less than or equal to 45 days).The zephyr ebv system ifu specifically references pleural effusion as a known side effect of this procedure.The reported event aligns with the experience observed in the liberate clinical study and is an expected side effect of the zephyr valve treatment.The reported event was foreseeable and clinically acceptable in view of the expected patient benefit from the treatment.
 
Event Description
On (b)(6) 2021, the patient underwent a bronchoscopic lung volume reduction procedure with three zephyr valves implanted in the right upper lobe.The post-procedure x-ray showed a loculated effusion.The patient had another bronchoscopy procedure to clear secretions on (b)(6) 2021.On (b)(6) 2021, the patient had a ct scan to address the effusion and 2 chest drains were placed.After resolution, both chest drains were removed on (b)(6) 2021 and patient was discharged on (b)(6) 2021.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZEPHYR ENDOBRONCHIAL VALVE (EBV)
Type of Device
ENDOBRONCHIAL VALVE
Manufacturer (Section D)
PULMONX CORPORATION
700 chesapeake drive
redwood city CA 94063
MDR Report Key11631611
MDR Text Key244378375
Report Number3007797756-2021-00053
Device Sequence Number1
Product Code NJK
UDI-Device Identifier00811907030126
UDI-Public(01)00811907030126(10)504877V70(17)220424
Combination Product (y/n)N
PMA/PMN Number
P180002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Patient Monitoring
Type of Report Initial
Report Date 04/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/07/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/24/2022
Device Model NumberZEPHYR 4.0 EBV
Device Catalogue NumberEBV-TS-4.0
Device Lot Number504877-V7.0
Was Device Available for Evaluation? No
Date Manufacturer Received03/08/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/24/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-